Hao Tang

Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis.

M. Mingueneau, J. Lyssikatos, T. Bohnert, 2021, Journal of medicinal chemistry.

MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response.

John C. Silbereis, R. Ransohoff, M. Mingueneau, 2021, Brain : a journal of neurology.

Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells

M. Mingueneau, Baohong Zhang, S. Belachew, 2021, Clinical & translational immunology.

Hepatic transcriptome discloses the potential targets of Xuefu Zhuyu Decoction ameliorating non-alcoholic fatty liver disease induced by high-fat diet

Jinghua Peng, Yiyang Hu, Wei Liu, 2023, Journal of traditional and complementary medicine.